Every 10-Q that H.B. Fuller Company (FUL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow FUL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FUL filings page.
H.B. Fuller reported stronger results for the quarter ended May 30, 2026, with net revenue of $950.3 million, up 5.8% from a year earlier, driven mainly by higher pricing and favorable currency.
Gross margin improved to 33.6%, and net income attributable to H.B. Fuller rose to $67.8 million, or $1.23 diluted EPS, versus $0.76 a year ago. Adjusted EBITDA increased 9.3% to $181.0 million. For the first six months, revenue grew 2.0% to $1.72 billion and diluted EPS reached $1.61.
After quarter-end, the company agreed to a recommended cash offer for Advanced Medical Solutions Group plc valuing its share capital at approximately 659,000 British pounds and implying an enterprise value of about 715,000 British pounds. To support the deal, H.B. Fuller arranged bridge credit facilities totaling up to $3.0 billion.
H.B. Fuller reported first-quarter 2026 net revenue of $770.8 million, down 2.3% from a year earlier, as lower volumes more than offset modest price gains. Gross margin improved to 30.6% from 28.8% thanks to higher pricing, lower raw material costs and contributions from recent acquisitions.
Net income attributable to H.B. Fuller rose to $21.0 million, or $0.38 per diluted share, compared with $13.2 million, or $0.24, a year ago. Adjusted EBITDA increased to $118.7 million, a 15.4% margin, up from 14.5%.
Hygiene, Health and Consumable Adhesives revenue declined, while Engineering Adhesives grew and Building Adhesive Solutions was essentially flat. Cash flow from operations was a small outflow of $4.0 million, significantly better than the prior-year outflow. Long-term debt was $2.08 billion, with a debt-to-total-capital ratio of 50.1%.
FULLER H B CO (FUL) reported several strategic transactions and financing updates during the quarter ending August 30, 2025. The company completed multiple acquisitions to expand regional and product presence, including ND Industries Asia, Inc. for approximately $8,310 (goodwill $2,422; other intangibles $2,400) and HS Butyl in the U.K. with other intangibles of $6,974 and goodwill of $3,805. Several acquisitions include holdbacks measured at fair value (example: a holdback of $28,922).
On financing, the company refinanced Term Loan B reducing margins to SOFR+175 bps with a SOFR floor of 50 bps (effective rate 6.07% at August 30, 2025) and retained the Feb 15, 2030 maturity. Interest rate and cross-currency swaps produced combined fair value liabilities reported as other liabilities (examples: $22,571 and $120,188). A $300,000 share repurchase authorization remains in place; repurchases of $56,930 were completed year‑to‑date. The company recorded environmental remediation liabilities of $2,818 and disclosed goodwill and intangible asset movements and discrete tax items affecting effective tax rates.
H.B. Fuller (NYSE:FUL) filed its Q2 2025 Quarterly Report (10-Q) for the period ended May 31 2025.
The XBRL detail indicates:
- Common shares outstanding: 53.95 M, down from 54.66 M, reflecting ongoing buybacks.
- Accounts payable: $160 M.
- Amended Term Loan B: $300 M bearing SOFR/Prime-based rates; interest expense disclosed.
- Restructuring: employee severance and other costs recorded through 5/31/25.
- Disposal of the North America flooring business treated as a non-discontinued sale.
- Active interest-rate swaps and net-investment hedges remain in place.
Results are reported across three segments—Hygiene, Engineering, and Building Adhesive Solutions—plus corporate unallocated items. No new guidance or dividend changes were noted.